PRISM MarketView

PRISM Top Takeaways from the Think Equity Conference: Game-Changing Innovators Reshaping Industries

New York, November 06, 2024 - PRISM MarketView - Innovation sets leading public companies apart in competitive markets. By introducing breakthrough products and disruptive approaches, innovative companies carve out unique positions and set trends. This differentiation he...

6 November 2024

PRISM NextGen Tech and AI: Spectral AI Plans to Spin Off Subsidiary Spectral IP

New York, November 06, 2024 - PRISM MarketView - A leading artificial intelligence (AI) company specializing in medical diagnostics to support faster and more precise treatment decisions in wound care, Spectral AI, Inc. (MDAI) has announced plans to spin off its subsidia...

6 November 2024

PRISM NextGen Tech and AI Earnings: Hackett Group Posts a Solid Q3 with Optimistic Outlook

New York, November 05, 2024 - PRISM MarketView - The IP platform-based, Gen AI consulting and advisory firm The Hackett Group (HCKT) reported its 3Q financial results. The company beat on EPS ($0.43 ex-items vs FactSet $0.40) and revenues ($79.8M vs FactSet $75.2M) in ad...

5 November 2024

SNDL Takes Bite Out of Canadian Cannabis Market. Emerges as Leading Producer of Edibles Upon Closing of Indiva Acquisition

New York, November 05, 2024 - PRISM MarketView - PRISM Cannabis Index company SNDL Inc. (SNDL) announced today that it has successfully completed its acquisition of Indiva Limited as part of the ongoing Companies’ Creditors Arrangement Act (“CCAA”) proceedings. The acqui...

5 November 2024

Quoin Initiates First Clinical Testing of Lead Product on Pediatric Netherton Syndrome Patient

New York, November 05, 2024 - PRISM MarketView - Quoin Pharmaceuticals (Nasdaq: QNRX) has initiated clinical testing of its lead product, QRX003, in a pediatric patient with Netherton Syndrome (NS) at Children’s Health Ireland. This trial marks the first time QRX003 is b...

5 November 2024

ZyVersa Therapeutics Unveils Positive Data Showing Potential to Protect Pancreatic Cells and Slow Progression from Obesity to Type 2 Diabetes, Shares Rise 41%

New York, November 05, 2024 - PRISM MarketView - ZyVersa Therapeutics (NASDAQ: ZVSA) announced positive data highlighting the potential of its inflammasome inhibitor, IC 100, in preserving pancreatic islet beta cells and reducing inflammation-related damage that contribu...

5 November 2024

Bionomics (BNOX) Soars After Securing AUS$1M Milestone Payment from Carina Biotech; Shares Up 185%

New York, November 05, 2024 - PRISM MarketView - Bionomics Limited (NASDAQ: BNOX), a biotech company specializing in treatments for central nervous system disorders, has received a milestone payment of AUS$1 million from Carina Biotech. This payment is part of an exclusi...

5 November 2024

Pre-Clinical Data Shows Corbus’ CRB-913 Could Sustain and Boost Weight Loss Following Semaglutide Therapy

New York, November 04, 2024 - PRISM MarketView - Corbus Pharmaceuticals (NASDAQ: CRBP) recently presented pre-clinical data on its investigational obesity treatment, CRB-913, at Obesity Week 2024. CRB-913, a CB1 inverse agonist with highly restricted peripheral action, d...

4 November 2024

Village Farms, is the Only Operator Selected to Testify at Marijuana Rescheduling Hearing

New York, November 04, 2024 - PRISM MarketView - One of the largest cannabis growers in the world Village Farms International, Inc. (VFF) was selected as one of 25 participants who will appear in the Drug Enforcement Administration’s (DEA) Administrative Law Judge hearin...

4 November 2024

PRISM Spotlight: Sidus Space Is on a Mission That Is Out of This World

New York, November 04, 2024 - PRISM MarketView - Sidus Space (SIDU) is a space mission enabler that provides flexible, cost-effective solutions including custom satellite design, payload hosting, mission management, space manufacturing and AI enhanced space-based sensor ...

4 November 2024